• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Intensive follow-up after colorectal cancer treatment associated with increased recurrence detection

bys25qthea
January 15, 2014
in Chronic Disease, Gastroenterology, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Regular CEA testing and CT imaging found more surgically curable recurrences than no scheduled follow-up 

2. Intensive follow-up did not lead to a mortality benefit compared to no scheduled follow-up 

Evidence Rating Level: 2 (Good)      

Study Rundown: Previous research has suggested that serum CEA (carcinoembryonic antigen) measurement and CT imaging are the preferred methods to detect isolated metastatic recurrences of colorectal cancer. The appropriate follow-up regimen after curative treatment, however, is unclear. This study (the FACS—Follow-up After Colorectal Surgery trial) identified the ability to detect surgically treatable and curable recurrences. The authors found that regular follow-up with CEA testing, CT imaging, both individually and together, increased detection of such recurrences compared to no scheduled follow-up. No mortality benefit was found, and this was likely due to the study being underpowered—it had 31% power to detect a 5% effect on survival. Overall, this study provides evidence for improved recurrence detection using CT imaging and CEA testing.

Click to read the study, published today in JAMA

Relevant Reading: Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial

RELATED REPORTS

Shortened duration of adjuvant chemotherapy in individuals with stage III colon cancer may be associated with noninferior overall survival

#VisualAbstract: Pembrolizumab linked to longer cancer-free period in advanced MSI-H-dMMR colorectal cancer

Addition of bevacizumab to standard therapy improves outcomes in metastatic colorectal cancer

In-Depth [randomized controlled trial]: This clinical trial randomized 1,211 patients who had previously received curative treatment for primary colorectal cancer to one of four follow-up groups: 1) CEA follow-up, 2) CT follow-up, 3) CEA and CT follow-up, and 4) minimum follow-up. All participants underwent a pre-trial colonoscopy to assess any remaining disease and were followed at varying intervals depending on the assigned group for three years. All three groups with more intensive follow-up had greater curative surgical treatment of recurrence than those assigned to the minimum follow-up group (absolute difference 6.6-8.0%, p=0.02). However, the detection difference between CEA and CT only (OR 5.10 and 6.71, respectively) relative to minimum follow-up was not significantly different than the detection difference of combined CEA and CT group (OR 5.24) relative to minimum follow-up. Moreover, no mortality benefit was found between intensive follow-up by any method and minimum follow-up (p=0.35).

By Jonathan Lichkus and Rif Rahman

More from this author: Micronutrient supplementation linked with HIV-disease progression, Obesity without metabolic syndrome still associated with increased mortality,Childhood poverty may harm brain development, Prostate-Specific Antigen screening of elderly men varies significantly in primary care, Younger women more likely than men to present with acute coronary syndrome without chest pain

© 2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: colon cancer
Previous Post

USPSTF recommends screening for gestational diabetes

Next Post

Mild hyperglycemia associated with low prevalence of vascular complications

RelatedReports

Racial differences in colorectal cancer survival linked to health at initial diagnosis
2 Minute Medicine

Shortened duration of adjuvant chemotherapy in individuals with stage III colon cancer may be associated with noninferior overall survival

June 2, 2021
#VisualAbstract: Occult Blood in Feces Is Associated With an Increased Risk of Ischemic Stroke and Myocardial Infarction
Chronic Disease

#VisualAbstract: Pembrolizumab linked to longer cancer-free period in advanced MSI-H-dMMR colorectal cancer

January 28, 2021
Radiofrequency ablation of hepatic metastases in colorectal cancer linked with improved survival
Gastroenterology

Addition of bevacizumab to standard therapy improves outcomes in metastatic colorectal cancer

August 31, 2020
Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening
Chronic Disease

Quick Take: Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer

September 25, 2019
Next Post
Soaring rates of peripheral artery disease, now over 200 million cases worldwide

Mild hyperglycemia associated with low prevalence of vascular complications

Social networks play key roles in parental vaccination decisions

Slight increased risk of intussusception linked to rotavirus vaccination

Endoscopic biliary drainage in acute cholangitis [Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
  • The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]
  • Relugolix combination therapy is efficacious for endometriosis-associated pain
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.